Constellation Brands (NYSE:STZ) Launches Corona Sunbrew Nationwide With NYC Event Sweepstakes

In This Article:

Constellation Brands recently launched Corona Sunbrew, sparking interest with its nationwide availability and a vibrant marketing campaign. This move, combined with the broader market upswing catalyzed by a U.S.-U.K. trade deal, could have supported the company's 11% share price increase over the last quarter. Despite facing a class action lawsuit and changes in its credit facility, the strong market performance and proactive product innovations likely provided momentum, aligning Constellation’s performance with the overall 7.7% market growth over the year. Other company adjustments, such as executive shifts and share buybacks, further added depth to the quarter's results.

We've identified 2 risks with Constellation Brands and understanding the impact should be part of your investment process.

NYSE:STZ Earnings Per Share Growth as at May 2025
NYSE:STZ Earnings Per Share Growth as at May 2025

Find companies with promising cash flow potential yet trading below their fair value.

The launch of Corona Sunbrew could potentially strengthen Constellation Brands' market position and revenue growth in the short term, adding to the positive momentum observed in its recent quarterly performance. As the company advances with its restructuring initiatives in Wine & Spirits and the expansion of its brewery in Veracruz, these moves are anticipated to support long-term margin enhancements and cost efficiencies. Over the past five years, Constellation's total shareholder return, including both share price appreciation and dividends, achieved a 31.98% increase, underscoring its potential to yield positive outcomes for long-term investors.

While Constellation Brands underperformed the US beverage industry over the past year, which declined by 5.2%, the stock offered a relatively more stable performance in the context of ongoing industry challenges. Analysts forecast limited revenue growth in the coming years, but earnings are projected to climb significantly as profit margins improve. With the share price currently at US$187.07, it stands at a 13.4% discount to the consensus price target of US$216.09, suggesting room for appreciation if earnings growth materializes as expected. The proactive management of new releases, such as Corona Sunbrew, along with strategic cost reductions, could play a crucial role in adjusting revenue and earnings forecasts positively.

Review our growth performance report to gain insights into Constellation Brands' future.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.